Press Releases

DVIDS - Georgia

RAMSTEIN AIR BASE, Germany — Landstuhl Regional Medical Center teamed up with the 86th Medical Group and NATO partner forces to co-host the Royal Danish Air Force Flyver Ruck March on Aug. 29. The event drew more than 500 in-person participants...

GlobeNewswire, Inc.

Company announcement – No. 47 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 10, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78),...

GlobeNewswire, Inc.

Study shows TT-P34 is safe and well tolerated in healthy volunteers and patients with early-stage Parkinson’s disease (PD), with pharmacokinetics confirming robust CNS exposure Early biomarker signals are consistent with pathway modulation in the...

GlobeNewswire, Inc.

Press release – No. 15 / 2026 Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference Copenhagen, Denmark, September 9, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company...

GlobeNewswire, Inc.

Company aims to link genetic variants to their biological functions and effects on disease Founding team includes disease genomics expert and Broad Institute Member Melina Claussnitzer, PHD CaMaRa’s business model builds on its founders’ proven...

GlobeNewswire, Inc.

Copenhagen, Denmark, Sept. 09, 2026 (GLOBE NEWSWIRE) -- The last meal before a big race can be make-or-break for runners.

GlobeNewswire, Inc.

COPENHAGEN, Denmark, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday,...

GlobeNewswire, Inc.

Company announcement No. 46 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 36, 2026) Copenhagen, Denmark, September 7, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...

GlobeNewswire, Inc.

COPENHAGEN, Denmark, Sept. 07, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will share the latest data from its Endocrinology Rare Disease programs during ESPE 2026, the annual congress of the European Society for...

GlobeNewswire, Inc.

COPENHAGEN, Denmark, Sept. 04, 2026 (GLOBE NEWSWIRE) -- The state-of-the-art quantum facility will strengthen Europe’s ability to design, manufacture and scale next-generation quantum chips, helping to position the continent as a global leader in...

GlobeNewswire, Inc.

Company announcement No. 45 / 2026 Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) Copenhagen, Denmark, September 2, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no....

GlobeNewswire, Inc.

Dr. Røpcke joins Resalis with extensive experience in clinical drug development as well as expertise in obesity and cardiometabolic therapy areas Torino, Italy, September 2, 2026 – Resalis Therapeutics, a biotechnology company pioneering...

GlobeNewswire, Inc.

Abstracts highlight potential of Autonomix’s transvascular technology across pain management and nervous system mapping THE WOODLANDS, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a...

GlobeNewswire, Inc.

Company announcement No. 44 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) Copenhagen, Denmark, August 31, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...

GlobeNewswire, Inc.

Company announcement – No. 43 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, August 28, 2026 – Zealand Pharma...

GlobeNewswire, Inc.

TARPON SPRINGS, Fla., September 11, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated dual PARP/Wnt pathway...

GlobeNewswire, Inc.

Delray Beach, FL , Aug. 24, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ estimates the global food as medicine Industry to grow from USD 254.15 billion in 2026 to USD 400.81 billion by 2031, registering a CAGR of 9.5% during the forecast period....

GlobeNewswire, Inc.

Company announcement – No. 42 / 2026 Zealand Pharma – Notification of holding of treasury shares Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...

GlobeNewswire, Inc.

Company announcement No. 41 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 34, 2026) Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...

EIN Presswire

An international consortium of experts outlines a unifying conceptual framework to transform precision diagnostics, therapeutics, and healthy aging strategies TORONTO, CANADA, August 20, 2026 /⁨EINPresswire.com⁩/ -- Today, an international team of...